SCHEMBL12331007

SCHEMBL12331007

CN(C)C(=O)N1CCOC(I)C1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GAA P10253 2/20 0.39
HSD17B10 Q99714 1/20 0.38
PDK1 Q15118 1/20 0.38
RAB9A P51151 2/20 0.34
USP30 Q70CQ3 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
HPGD P15428 1/20 0.33
PDE4B Q07343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12233567 0.80 PDK1 (0.51) MAPTMEN1KMT2ASMN1; SMN2HSD17B10
SCHEMBL6868433 0.79 SMN1; SMN2 (0.47) SMN1; SMN2PDK1
SCHEMBL14773659 0.79 CHRNB2 (0.42) SMN1; SMN2PDK1CYP3A4PDE4B
SCHEMBL12331619 0.79 CHRNB2 (0.42) SMN1; SMN2PDK1CYP3A4PDE4B
SCHEMBL12331071 0.79 CHRNB2 (0.42) SMN1; SMN2PDK1CYP3A4PDE4B
SCHEMBL12233297 0.77 MAPT (0.46) MAPTMEN1KMT2ASMN1; SMN2GAA
SCHEMBL12331002 0.76 PDK1 (0.35) PDK1
SCHEMBL12331003 0.75 POLB (0.47) SMN1; SMN2PDK1PDE4B
SCHEMBL12331039 0.74 HPGD (0.45) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14773445 0.73 PDK1 (0.32) GAAPDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013036684-A1 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS SATORI PHARMACEUTICALS, INC (US) 2013-03-14 WO disclosed
WO-2011109657-A1 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS SATORI PHARMACEUTICALS, INC. (US) 2011-09-09 WO disclosed